Back to Search
Start Over
Gilead's Daniel O'Day relishes Dietmar Berger reunion as cancer specialist agrees to join from Sanofi.
- Source :
- FierceBiotech; 12/13/2024, pN.PAG-N.PAG, 1p
- Publication Year :
- 2024
-
Abstract
- Dietmar Berger's appointment reunites Gilead CEO Daniel O'Day with a key member of the oncology team from his time at Roche. [ABSTRACT FROM AUTHOR]
- Subjects :
- ONCOLOGISTS
EXECUTIVES
CHIEF executive officers
REUNIONS
ONCOLOGY
Subjects
Details
- Language :
- English
- Database :
- Complementary Index
- Journal :
- FierceBiotech
- Publication Type :
- Periodical
- Accession number :
- 181652801